Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The large-conductance calcium- and voltage-activated potassium (BK) channel alpha subunit forms the functional core of the BK channel, assembling as a tetramer to create the ion-conducting pore. BK channels are uniquely activated by both membrane depolarization and increases in intracellular Ca2+, allowing them to respond rapidly to changes in cellular activity. Upon activation, they permit rapid efflux of K+, leading to membrane hyperpolarization and decreased cellular excitability. Dysfunction or mutations can lead to disorders such as hypertension, hearing loss, and epilepsy. Pharmacological modulation is being explored for therapeutic purposes.
Activation of BK channels, leading to potassium efflux and membrane hyperpolarization.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Large-Conductance Calcium-Activated Potassium Channel Alpha Subunit (BK channel alpha subunit).